Skip to main content

Table 1 Baseline characteristics by preadmission statin use among 12,483 ICU patients, Aarhus University Hospital, Denmark 2001 to 2007

From: Preadmission statin use and one-year mortality among patients in intensive care - A cohort study

 

Statin use

n (%)

No statin use

n (%)

Overall

1882 (14.3%)

10,601 (85.7%)

Age group (years)

  

45-60

373 (19.8%)

3725 (35.1%)

61-75

1095 (58.2%)

4421 (41.7%)

76+

414 (22.0%)

2455 (23.2%)

Gender

  

Male

1193 (63.4%)

6085 (57.4%)

Female

689 (36.6%)

4516 (42.6%)

Comorbidity score*

  

Low

283 (15.0%)

3563 (33.6%)

Medium

862 (45.8%)

4280 (40.4%)

High

737 (39.2%)

2758 (26.0%)

Comorbidity diagnosis**

  

Ischemic heart disease

658 (35.0%)

950 (9.0%)

Congestive heart failure

406 (21.6%)

1113 (10.5%)

Peripheral vascular disease

451 (24.0%)

1050 (9.9%)

Cerebrovascular disease

468 (24.9%)

1393 (13.1%)

COPD

339 (18.0%)

1836 (17.3%)

Diabetes

456 (24.2%)

879 (8.3%)

Cancer

299 (15.9%)

2401 (22.5%)

Renal disease

171 (9.0%)

586 (5.4%)

Alcoholism-related diseases

137 (7.3%)

1305 (12.3%)

Cardiovascular drug use

  

ACE inhibitors

1003 (53.3%)

1860 (17.6%)

Beta blockers

983 (52.2%)

1706 (16.1%)

Low-dose aspirin

336 (17.9%)

674 (6.4%)

Marital status

  

Married

1141 (60.6%)

5664 (53.4%)

Divorced

251 (13.3%)

1512 (14.3%)

Widowed

345 (18.3%)

2033 (19.2%)

Never married

139 (7.4%)

1135 (10.7%)

Unknown

6 (0.3%)

257 (2.4%)

  1. *Level of Charlson comorbidity index.
  2. ** Patients may have more than one comorbidity.
  3. ACE: angiotensin converting enzyme; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit.